218 drugs are required to reduce prices nationwide

Source: Heilongjiang drug collection network ▍ finishing: Cypress blue corn The government asked 218 drugs to declare the lowest price in the country On December 2, Heilongjiang drug centralized purchase network released the notice on the implementation of price linkage of non selected drugs in the alliance area Heilongjiang said that among the 25 varieties involved in the centralized drug purchase document in the alliance region released by the joint procurement office, other manufacturers of non selected drugs that have already purchased in the centralized drug purchase network of Heilongjiang province need to submit the national minimum price (excluding the pilot drug centralized purchase and use organized by the state and the pilot to expand the regional range of the selected price), specifications If the package has a difference ratio relationship, it shall be calculated according to the price difference ratio rule (see the end of the article for the contents) According to the catalogue, 218 drugs need to declare the lowest price in China Heilongjiang said that relevant pharmaceutical manufacturers should declare within the prescribed time limit and ensure the authenticity and accuracy of the declaration For enterprises that fail to declare price reduction within the specified time limit (December 2-december 4), the qualification for online trading of corresponding products will be suspended The price of this linkage does not include the 4 + 7 middle selection price The price linkage excludes the price linked to the quantity and price in other places to reserve space for the next price reduction in the volume purchase negotiation of the enterprise The leading group of the State Council on deepening the reform of the medical and health system issued on November 29 "a number of policies and measures on further deepening the reform of the medical and health system with centralized purchase and use of drugs as the breakthrough point", which stated that the national public purchase market for drugs and the multi-party linkage purchase pattern should be established According to the document, relying on the provincial drug centralized procurement platform, we need to build a unified and open drug public procurement market, unify coding, standards and functional specifications, promote the interconnection and resource sharing of drug prices and other related information, and promote the national linkage of drug prices The volume purchase not only allows individual drugs to reduce prices, but also forms a set of centralized purchase mode Countries that have evaluated drugs organize negotiation and purchase through price negotiation For drugs that fail to pass the consistency evaluation, they will also lower the price by linking the quantity and price That is to say, for drugs that are not included in the scope of centralized procurement and use of national organizations, provinces should learn from the experience of centralized procurement and use of national organizations, and adopt independent or cross regional alliance and other ways to increase reform and innovation in the scope of procurement of drugs, the criteria for shortlisting and the form of centralized procurement, so as to form a work pattern of mutual promotion between the state and local governments In addition, in the document on several policies and measures to further deepen the reform of the medical and health system with centralized purchase and use of drugs as the breakthrough point, it also encourages exploration to form reasonable prices by means of group purchase, joint purchase of specialized hospitals and medical joint purchase, and encourages the active participation of non-public medical institutions and social pharmacies In this way, the price of drugs after price reduction will be basically the same across the country, and there is no big price difference between different regions, so pharmaceutical enterprises should make a unified plan for the national market when negotiating Attachment: